Provided by Tiger Fintech (Singapore) Pte. Ltd.

Kalvista Pharmaceuticals Inc

11.64
-0.5400-4.43%
Post-market: 11.640.00000.00%19:43 EDT
Volume:466.89K
Turnover:5.48M
Market Cap:578.69M
PE:-3.13
High:12.22
Open:12.06
Low:11.57
Close:12.18
Loading ...
Mar 11, 2021

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Mar 11, 2021

Major Issues Report

8-K - Current report
Mar 11, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Feb 16, 2021

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Feb 16, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 12, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 11, 2021

Major Issues Report

8-K - Current report
Feb 08, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 02, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Jan 27, 2021

Major Issues Report

8-K - Current report
Dec 18, 2020

Major Issues Report

8-K - Current report
Dec 10, 2020

Major Issues Report

8-K - Current report
Dec 10, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Dec 01, 2020

Major Issues Report

8-K - Current report
Nov 16, 2020

Major Issues Report

8-K - Current report
Oct 02, 2020

Major Issues Report

8-K - Current report
Sep 14, 2020

Major Issues Report

8-K - Current report
Sep 14, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 02, 2020

Major Issues Report

8-K - Current report
Jul 01, 2020

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]